216 related articles for article (PubMed ID: 21760917)
1. Stage-related alterations in renal cell carcinoma--comprehensive quantitative analysis by 2D-DIGE and protein network analysis.
Junker H; Venz S; Zimmermann U; Thiele A; Scharf C; Walther R
PLoS One; 2011; 6(7):e21867. PubMed ID: 21760917
[TBL] [Abstract][Full Text] [Related]
2. Identification of clinically relevant protein targets in prostate cancer with 2D-DIGE coupled mass spectrometry and systems biology network platform.
Ummanni R; Mundt F; Pospisil H; Venz S; Scharf C; Barett C; Fälth M; Köllermann J; Walther R; Schlomm T; Sauter G; Bokemeyer C; Sültmann H; Schuppert A; Brümmendorf TH; Balabanov S
PLoS One; 2011 Feb; 6(2):e16833. PubMed ID: 21347291
[TBL] [Abstract][Full Text] [Related]
3. Potential predictive plasma biomarkers for cervical cancer by 2D-DIGE proteomics and Ingenuity Pathway Analysis.
Guo X; Hao Y; Kamilijiang M; Hasimu A; Yuan J; Wu G; Reyimu H; Kadeer N; Abudula A
Tumour Biol; 2015 Mar; 36(3):1711-20. PubMed ID: 25427637
[TBL] [Abstract][Full Text] [Related]
4. Proteomic analysis reveals differentially secreted proteins in the urine from patients with clear cell renal cell carcinoma.
Sandim V; Pereira Dde A; Kalume DE; Oliveira-Carvalho AL; Ornellas AA; Soares MR; Alves G; Zingali RB
Urol Oncol; 2016 Jan; 34(1):5.e11-25. PubMed ID: 26420021
[TBL] [Abstract][Full Text] [Related]
5. Proteomic analysis in clear cell renal cell carcinoma: identification of differentially expressed protein by 2-D DIGE.
Raimondo F; Salemi C; Chinello C; Fumagalli D; Morosi L; Rocco F; Ferrero S; Perego R; Bianchi C; Sarto C; Pitto M; Brambilla P; Magni F
Mol Biosyst; 2012 Apr; 8(4):1040-51. PubMed ID: 22315040
[TBL] [Abstract][Full Text] [Related]
6. Proteomics approaches for identification of tumor relevant protein targets in pulmonary squamous cell carcinoma by 2D-DIGE-MS.
Lihong H; Linlin G; Yiping G; Yang S; Xiaoyu Q; Zhuzhu G; Xiaohan Y; Xin Z; Liyan X; Shujuan S
PLoS One; 2014; 9(4):e95121. PubMed ID: 24740010
[TBL] [Abstract][Full Text] [Related]
7. Systematic comparative protein expression profiling of clear cell renal cell carcinoma: a pilot study based on the separation of tissue specimens by two-dimensional gel electrophoresis.
Lichtenfels R; Dressler SP; Zobawa M; Recktenwald CV; Ackermann A; Atkins D; Kersten M; Hesse A; Puttkammer M; Lottspeich F; Seliger B
Mol Cell Proteomics; 2009 Dec; 8(12):2827-42. PubMed ID: 19752005
[TBL] [Abstract][Full Text] [Related]
8. Pathway analysis of kidney cancer using proteomics and metabolic profiling.
Perroud B; Lee J; Valkova N; Dhirapong A; Lin PY; Fiehn O; Kültz D; Weiss RH
Mol Cancer; 2006 Nov; 5():64. PubMed ID: 17123452
[TBL] [Abstract][Full Text] [Related]
9. 2D-difference gel electrophoretic proteomic analysis of a cell culture model of alveolar rhabdomyosarcoma.
Pressey JG; Pressey CS; Robinson G; Herring R; Wilson L; Kelly DR; Kim H
J Proteome Res; 2011 Feb; 10(2):624-36. PubMed ID: 21110518
[TBL] [Abstract][Full Text] [Related]
10. Identification of differentially-expressed proteins between early submucosal non-invasive and invasive colorectal cancer using 2D-DIGE and mass spectrometry.
Zhang J; Song MQ; Zhu JS; Zhou Z; Xu ZP; Chen WX; Chen NW
Int J Immunopathol Pharmacol; 2011; 24(4):849-59. PubMed ID: 22230392
[TBL] [Abstract][Full Text] [Related]
11. iTRAQ-based quantitative proteomic analysis reveals potential early diagnostic markers of clear-cell Renal cell carcinoma.
Zhang L; Jiang H; Xu G; Chu N; Xu N; Wen H; Gu B; Liu J; Mao S; Na R; Jing Y; Ding Q; Zhang Y; Wang L
Biosci Trends; 2016 Jul; 10(3):210-9. PubMed ID: 27319973
[TBL] [Abstract][Full Text] [Related]
12. [Quantitative and comparative proteomics analysis in clear cell renal cell carcinoma and adjacent noncancerous tissues by 2-D DIGE].
Chen ZF; Xiao YJ; Huang ZH; Chen T; Zhao SC; Jiang YD; Wu P; Zheng SB
Nan Fang Yi Ke Da Xue Xue Bao; 2017 Nov; 37(11):1517-1522. PubMed ID: 29180334
[TBL] [Abstract][Full Text] [Related]
13. Proteomics identified nuclear N-myc downstream-regulated gene 1 as a prognostic tissue biomarker candidate in renal cell carcinoma.
Hosoya N; Sakumoto M; Nakamura Y; Narisawa T; Bilim V; Motoyama T; Tomita Y; Kondo T
Biochim Biophys Acta; 2013 Dec; 1834(12):2630-9. PubMed ID: 23999030
[TBL] [Abstract][Full Text] [Related]
14. Combined analysis of transcriptome and proteome data as a tool for the identification of candidate biomarkers in renal cell carcinoma.
Seliger B; Dressler SP; Wang E; Kellner R; Recktenwald CV; Lottspeich F; Marincola FM; Baumgärtner M; Atkins D; Lichtenfels R
Proteomics; 2009 Mar; 9(6):1567-81. PubMed ID: 19235166
[TBL] [Abstract][Full Text] [Related]
15. Primary cell cultures arising from normal kidney and renal cell carcinoma retain the proteomic profile of corresponding tissues.
Perego RA; Bianchi C; Corizzato M; Eroini B; Torsello B; Valsecchi C; Di Fonzo A; Cordani N; Favini P; Ferrero S; Pitto M; Sarto C; Magni F; Rocco F; Mocarelli P
J Proteome Res; 2005; 4(5):1503-10. PubMed ID: 16212400
[TBL] [Abstract][Full Text] [Related]
16. Grade-dependent proteomics characterization of kidney cancer.
Perroud B; Ishimaru T; Borowsky AD; Weiss RH
Mol Cell Proteomics; 2009 May; 8(5):971-85. PubMed ID: 19164279
[TBL] [Abstract][Full Text] [Related]
17. Proteomics analysis of malignant and benign prostate tissue by 2D DIGE/MS reveals new insights into proteins involved in prostate cancer.
Davalieva K; Kostovska IM; Kiprijanovska S; Markoska K; Kubelka-Sabit K; Filipovski V; Stavridis S; Stankov O; Komina S; Petrusevska G; Polenakovic M
Prostate; 2015 Oct; 75(14):1586-600. PubMed ID: 26074449
[TBL] [Abstract][Full Text] [Related]
18. 2D-DIGE analysis of ovarian cancer cell responses to cytotoxic gold compounds.
Guidi F; Puglia M; Gabbiani C; Landini I; Gamberi T; Fregona D; Cinellu MA; Nobili S; Mini E; Bini L; Modesti PA; Modesti A; Messori L
Mol Biosyst; 2012 Apr; 8(4):985-93. PubMed ID: 22134777
[TBL] [Abstract][Full Text] [Related]
19. Mass spectrometric characterization of protein structure details refines the proteome signature for invasive ductal breast carcinoma.
Röwer C; Koy C; Hecker M; Reimer T; Gerber B; Thiesen HJ; Glocker MO
J Am Soc Mass Spectrom; 2011 Mar; 22(3):440-56. PubMed ID: 21472563
[TBL] [Abstract][Full Text] [Related]
20. Impact of cisplatin administration on protein expression levels in renal cell carcinoma: a proteomic analysis.
Vasko R; Mueller GA; von Jaschke AK; Asif AR; Dihazi H
Eur J Pharmacol; 2011 Nov; 670(1):50-7. PubMed ID: 21924258
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
